PortalPublikationenEfficacy of mogamulizumab in mycosis fungoides by patient bl...

Efficacy of mogamulizumab in mycosis fungoides by patient blood involvement and time to response analysis in mycosis fungoides and Sézary syndrome: a post hoc analysis of the MAVORIC study

Standard

Efficacy of mogamulizumab in mycosis fungoides by patient blood involvement and time to response analysis in mycosis fungoides and Sézary syndrome: a post hoc analysis of the MAVORIC study. / Beylot-Barry, Marie; Booken, Nina; Weishaupt, Carsten; Medley, Michael; Sun, Wei; Rosen, Jan-Paul.

in: EUR J CANCER, Jahrgang 156 , Nr. Suppl 1, 10.2021, S. S47-S48.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Konferenzaufsatz in Fachzeitschrift › Forschung › Begutachtung

Harvard

Beylot-Barry, M, Booken, N, Weishaupt, C, Medley, M, Sun, W & Rosen, J-P 2021, 'Efficacy of mogamulizumab in mycosis fungoides by patient blood involvement and time to response analysis in mycosis fungoides and Sézary syndrome: a post hoc analysis of the MAVORIC study', EUR J CANCER, Jg. 156 , Nr. Suppl 1, S. S47-S48. https://doi.org/10.1016/S0959-8049(21)00714-0

APA

Beylot-Barry, M., Booken, N., Weishaupt, C., Medley, M., Sun, W., & Rosen, J-P. (2021). Efficacy of mogamulizumab in mycosis fungoides by patient blood involvement and time to response analysis in mycosis fungoides and Sézary syndrome: a post hoc analysis of the MAVORIC study. EUR J CANCER, 156 (Suppl 1), S47-S48. https://doi.org/10.1016/S0959-8049(21)00714-0

Vancouver

Beylot-Barry M, Booken N, Weishaupt C, Medley M, Sun W, Rosen J-P. Efficacy of mogamulizumab in mycosis fungoides by patient blood involvement and time to response analysis in mycosis fungoides and Sézary syndrome: a post hoc analysis of the MAVORIC study. EUR J CANCER. 2021 Okt;156 (Suppl 1):S47-S48. https://doi.org/10.1016/S0959-8049(21)00714-0

Bibtex

@article{2cfedc45a7eb4b0a98943a4736570bbe,
title = "Efficacy of mogamulizumab in mycosis fungoides by patient blood involvement and time to response analysis in mycosis fungoides and S{\'e}zary syndrome: a post hoc analysis of the MAVORIC study",
author = "Marie Beylot-Barry and Nina Booken and Carsten Weishaupt and Michael Medley and Wei Sun and Jan-Paul Rosen",
year = "2021",
month = oct,
doi = "10.1016/S0959-8049(21)00714-0",
language = "English",
volume = "156 ",
pages = "S47--S48",
journal = "EUR J CANCER",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "Suppl 1",

}

RIS

TY - JOUR

T1 - Efficacy of mogamulizumab in mycosis fungoides by patient blood involvement and time to response analysis in mycosis fungoides and Sézary syndrome: a post hoc analysis of the MAVORIC study

AU - Beylot-Barry, Marie

AU - Booken, Nina

AU - Weishaupt, Carsten

AU - Medley, Michael

AU - Sun, Wei

AU - Rosen, Jan-Paul

PY - 2021/10

Y1 - 2021/10

U2 - 10.1016/S0959-8049(21)00714-0

DO - 10.1016/S0959-8049(21)00714-0

M3 - Conference article in journal

C2 - 34649657

VL - 156

SP - S47-S48

JO - EUR J CANCER

JF - EUR J CANCER

SN - 0959-8049

IS - Suppl 1

ER -